- Home
- Publications
- Publication Search
- Publication Details
Title
Rapidly inducible Cas9 and DSB-ddPCR to probe editing kinetics
Authors
Keywords
-
Journal
NATURE METHODS
Volume 14, Issue 9, Pages 891-896
Publisher
Springer Nature
Online
2017-07-24
DOI
10.1038/nmeth.4368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
- (2017) Avi Ashkenazi et al. NATURE REVIEWS DRUG DISCOVERY
- Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
- (2017) Serif Senturk et al. Nature Communications
- Quantification and genome-wide mapping of DNA double-strand breaks
- (2016) Marie-Chantal Grégoire et al. DNA REPAIR
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
- (2016) Benjamin L Oakes et al. NATURE BIOTECHNOLOGY
- Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
- (2016) Christopher D Richardson et al. NATURE BIOTECHNOLOGY
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
- (2016) John G Doench et al. NATURE BIOTECHNOLOGY
- A computationally engineered RAS rheostat reveals RAS–ERK signaling dynamics
- (2016) John C Rose et al. Nature Chemical Biology
- Multidimensional chemical control of CRISPR–Cas9
- (2016) Basudeb Maji et al. Nature Chemical Biology
- A chemical-inducible CRISPR–Cas9 system for rapid control of genome editing
- (2016) Kaiwen Ivy Liu et al. Nature Chemical Biology
- DSBCapture: in situ capture and sequencing of DNA breaks
- (2016) Stefanie V Lensing et al. NATURE METHODS
- Overhang polarity of chromosomal double-strand breaks impacts kinetics and fidelity of yeast non-homologous end joining
- (2016) Zhuobin Liang et al. NUCLEIC ACIDS RESEARCH
- Probing the impact of chromatin conformation on genome editing tools
- (2016) Xiaoyu Chen et al. NUCLEIC ACIDS RESEARCH
- In vivoblunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
- (2016) Jonathan M. Geisinger et al. NUCLEIC ACIDS RESEARCH
- Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity
- (2016) Duy P. Nguyen et al. Nature Communications
- Nucleosome breathing and remodeling constrain CRISPR-Cas9 function
- (2016) R Stefan Isaac et al. eLife
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- A split-Cas9 architecture for inducible genome editing and transcription modulation
- (2015) Bernd Zetsche et al. NATURE BIOTECHNOLOGY
- Photoactivatable CRISPR-Cas9 for optogenetic genome editing
- (2015) Yuta Nihongaki et al. NATURE BIOTECHNOLOGY
- Small molecule–triggered Cas9 protein with improved genome-editing specificity
- (2015) Kevin M Davis et al. Nature Chemical Biology
- CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo
- (2015) Miguel A Moreno-Mateos et al. NATURE METHODS
- Cas9 gRNA engineering for genome editing, activation and repression
- (2015) Samira Kiani et al. NATURE METHODS
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- Dynamics of CRISPR-Cas9 genome interrogation in living cells
- (2015) Spencer C. Knight et al. SCIENCE
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
- (2014) Hiroshi Nishimasu et al. CELL
- DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
- (2014) Samuel H. Sternberg et al. NATURE
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
- (2014) Zhi-Fu Tao et al. ACS Medicinal Chemistry Letters
- Structure-guided design of a selective BCL-XL inhibitor
- (2013) Guillaume Lessene et al. Nature Chemical Biology
- Absolute quantification by droplet digital PCR versus analog real-time PCR
- (2013) Christopher M Hindson et al. NATURE METHODS
- Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency
- (2012) Guo Wei et al. CANCER CELL
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research
- (2011) Alesia Ivashkevich et al. CANCER LETTERS
- RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
- (2011) Po-Ssu Huang et al. PLoS One
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- 3V: cavity, channel and cleft volume calculator and extractor
- (2010) N. R. Voss et al. NUCLEIC ACIDS RESEARCH
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- A Small Molecule-Regulated Guanine Nucleotide Exchange Factor
- (2009) Inna Goreshnik et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
- (2009) R. Z. Cer et al. NUCLEIC ACIDS RESEARCH
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started